Literature DB >> 31269455

Comparative performance of QuantiFERON-TB Gold versus skin test with tuberculosis recombinant allergen (Diaskintest) among patients with suspected pulmonary tuberculosis in Russia.

Irina Y Nikitina1, Natalya L Karpina2, Olga V Kasimceva3, Vladislav Y Gergert4, Atadzhan Ergeshov5, Irina V Lyadova6.   

Abstract

BACKGROUND: The early identification of Mycobacterium tuberculosis infection can prevent tuberculosis (TB) transmission. A skin test with a tuberculosis recombinant allergen (Diaskintest) is a new method for identification that has been implemented in Russia. This study was performed to compare the performances of Diaskintest and QuantiFERON-TB Gold (QFT) in adults and children with suspected TB in Moscow, Russia.
METHODS: Adults (n=85) and children (n=96) were tested using Diaskintest and QFT. Concordance and comparative analyses were performed.
RESULTS: Diaskintest and QFT were concordant in 84% of adults and 90% of children (overall concordance 87%, κ>0.6, Kc>0.5). The concordance between QFT, Diaskintest, and the final diagnosis was good in adults (86% and 81%, respectively) and moderate in children (77% and 79%, respectively). In adults, QFT had a higher sensitivity for detecting TB than Diaskintest (82% and 68%, respectively); in children, Diaskintest was more sensitive (73% and 65%, respectively). In patients with a confirmed TB diagnosis, negative Diaskintest/QFT results were associated with low disease activity. Combined Diaskintest/QFT results identified TB patients with higher sensitivity and specificity than each test separately.
CONCLUSIONS: Diaskintest is a low-cost diagnostic tool that shows a test positivity rate similar to QFT and can be used in combination with QFT as an adjunctive test for TB diagnosis.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Diaskintest; QuantiFERON-TB Gold; Skin test with tuberculosis recombinant allergen; Tuberculosis

Mesh:

Substances:

Year:  2019        PMID: 31269455     DOI: 10.1016/j.ijid.2019.06.014

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  3 in total

1.  Induration or erythema diameter not less than 5 mm as results of recombinant fusion protein ESAT6-CFP10 skin test for detecting M. tuberculosis infection.

Authors:  Hui Zhang; Ling Wang; Feng Li; Shuihua Lu; Jielai Xia
Journal:  BMC Infect Dis       Date:  2020-09-18       Impact factor: 3.090

2.  Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV.

Authors:  Ricardo E Steffen; Marcia Pinto; Afranio Kritski; Anete Trajman
Journal:  Sci Rep       Date:  2020-12-11       Impact factor: 4.379

Review 3.  The definition of tuberculosis infection based on the spectrum of tuberculosis disease.

Authors:  Giovanni Battista Migliori; Catherine W M Ong; Linda Petrone; Lia D'Ambrosio; Rosella Centis; Delia Goletti
Journal:  Breathe (Sheff)       Date:  2021-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.